230 Results for "

SCLY

" in MedChemExpress (MCE) Product Catalog:
Products (230)

230 Results for "SCLY" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-148559
CAS No.: 1857340-78-3
Purity:  99.21%
Target:  

Liposome

Research Areas:  

Cancer

4A3-SC8 is a modular degradable dendrimer that enables small RNAs to extend survival in an aggressive liver cancer model .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W010983
CAS No.: 170569-86-5
SC-236 is an orally active COX-2 specific inhibitor (IC50 = 10 nM) and a PPARγ agonist. SC-236 suppresses activator protein-1 (AP-1) through c-Jun NH2-terminal kinase. SC-236 exerts anti-inflammatory effects by suppressing phosphorylation of ERK in a murine model .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103226
CAS No.: 423169-68-0
Purity:  99.93%
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology

SC-57461A is a potent, orally active, nonpeptide, and selective inhibitor of Leukotriene A4 (LTA4) hydrolase with IC50s of 2.5 nM, 3 nM, and 23 nM for recombinant human, mouse, and rat LTA4 hydrolase, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-126681
CAS No.: 2259318-46-0
Purity:  98.01%
Synonyms: NHS-VC-PAB-MMAE
Research Areas:  

Cancer

SC-VC-PAB-MMAE (NHS-VC-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker SC-VC-PAB .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-124876
CAS No.: 685121-45-3
Purity:  99.89%
Synonyms: SC-D
Target:  

α-synuclein

Research Areas:  

Neurological Disease

SynuClean-D (SC-D) is an inhibitor of α-synuclein aggregation, disrupts mature amyloid fibrils, prevents fibril propagation, and abolishes the degeneration of dopaminergic neurons in an animal model of Parkinson’s disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145799
CAS No.: 1857341-90-2
Purity:  95.98%
Target:  

Liposome

Research Areas:  

Cancer

5A2-SC8 is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145799A
Purity:  98.03%
Target:  

Liposome

Research Areas:  

Cancer

5A2-SC8 TFA is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 TFA LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-155656
CAS No.: 851471-44-8
Purity:  98.26%
Target:  

Dynamin

Research Areas:  

Inflammation/Immunology

nti-inflammatory agent 49 (compound SC9) is a quite potent and selective inhibitor of Drp1-Fis1 interaction and can reduce FIS1-mediated mitochondrial dysfunction. The IC50 of SC9 inhibiting GTPase in vitro is 270 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132306
CAS No.: 2708934-53-4
Purity:  98.02%
Synonyms: CCF981
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CL pro (SC2) inhibitor with an IC50 of 68 nM. CCF0058981 inhibits SC1 (SARS-CoV-1 3CL pro) with an IC50 of 19 nM. CCF0058981 has antiviral efficacy and has the potential for COVID-19 research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17509
CAS No.: 169590-41-4
Synonyms: SC 046; SC 46; SC 59046
Deracoxib (SC 046; SC 59046), an orally active COX-2 inhibitor, is a veterinary nonsteroidal anti-inflammatory agent used exclusively in dogs. Deracoxib inhibits the COX-2 enzyme to reduce the production of prostaglandins, effectively controlling pain and inflammation after canine soft tissue surgery. Deracoxib reduces the inhibition of COX-1 and lowers the risk of gastrointestinal side effects. Deracoxib induces tumor cell cycle arrest and apoptosis, and shows anti-tumor activity in canine osteosarcoma, breast tumors and bladder transitional cell carcinomas .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P0323A
Synonyms: LCMV GP(33-41) C-peptide TFA
Target:  

Arenavirus

Research Areas:  

Infection

GP(33-41) TFA, a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus. GP(33-41) TFA can upregulate H-2D b molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W591424
CAS No.: 92451-01-9
Synonyms: mPEG2000-SC; mPEG2000-Succinimidyl ester
m-PEG2000-NHS ester (mPEG2000-SC) is a reagent with both cell adhesion inhibition and peptide conjugation functions. The NHS ester group of m-PEG2000-NHS ester forms stable amide bonds with primary amine-containing molecules (e.g., the N-terminus of MMP-2-cleavable octapeptide) to generate mPEG-peptide intermediates for liposome surface modification. When m-PEG2000-NHS ester is immobilized on a cystamine-modified gold surface, it can construct an in vitro model for cell adhesion kinetic studies, and higher PEG density and thicker layers correlate with lower cell adhesion rates. m-PEG2000-NHS ester can synthesize MMP-2-responsive PEGylated lipid conjugates to achieve MMP-triggered dePEGylation in the tumor microenvironment. m-PEG2000-NHS ester can be used in studies related to colon cancer and other conditions .
loading...
    loading...
Cat. No.: HY-171099
CAS No.: 2245949-62-4
Synonyms: LI-2124
Target:  

IPK Superfamily

SC-919 is an orally active IP6K inhibitor, with an IC50 of < 5.2 nM against IP6K1, < 3.8 nM against IP6K2, and 0.65 nM against IP6K3. By inhibiting the activity of IP6K, SC-919 reduces intracellular IP7 levels, thereby suppressing XPR1-mediated cellular phosphate efflux. SC-919 increases intracellular phosphate and ATP levels while reducing phosphate entry into the bloodstream, thus decreasing plasma phosphate levels. SC-919 can be used in research related to chronic kidney disease and hyperphosphatemia .
loading...
    loading...
Cat. No.: HY-148194
CAS No.: 1977557-97-3
Purity:  99.97%
Research Areas:  

Cancer

SC239 is a cleavable 2-aminophenyl hemiasterlin agent-linker. SC239 can be as the agent-linker for ADC . SC239 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-177069
CAS No.: 1857340-77-2
Target:  

Liposome

Research Areas:  

Others

4A3-SC7 is a polymer of 4A3 amine and is an ionizable lipid component. 4A3-SC7 can be used to prepare lipid nanoparticles (LNPs) to construct a selective organ targeting (SORT) LNP platform .
loading...
    loading...
Cat. No.: HY-161409
Research Areas:  

Cancer

SC912 is an AR-V7 inhibitor (IC50 = 0.36 μM). SC912 possesses safety, potency and selectivity. SC912 binds directly to AR-FL and AR-V7 proteins, inhibites nuclear localization and chromatin binding capabilities. SC912 exerts anticancer activity through inhibition of proliferation, induction of cell cycle arrest and apoptosis .
loading...
    loading...
Cat. No.: HY-131236
CAS No.: 324022-08-4
Purity:  99.92%
Target:  

EBV

Research Areas:  

Cancer

EBNA1-IN-SC7 (compound SC7) is a selective Epstein-Barr nuclear antigen 1 (EBNA1) inhibitor that interferes with EBNA1-DNA binding activity with an IC50 value of 23 μM. EBNA1-IN-SC7 is used in EBV (Epstein-Barr virus)-related cancer research .
loading...
    loading...
Cat. No.: HY-144880
CAS No.: 1977557-86-0
Purity:  99.52%
Synonyms: 3-Aminophenyl Hemiasterlin
Research Areas:  

Cancer

SC209 (3-Aminophenyl Hemiasterlin) is a 3-aminophenyl hemiasterlin derivative that serves as a cytotoxin for ADCs, targeting tubulin. SC209 has reduced potential for drug efflux via P-glycoprotein 1 drug pump compared with other tubulin-targeting payloads. SC209 exhibits antitumor activity and can be used in the synthesis of ADC molecules .
loading...
    loading...
Cat. No.: HY-126693
CAS No.: 2259318-47-1
Purity:  93.25%
Research Areas:  

Cancer

SC-VC-PAB-DM1 is a agent-linker conjugate for ADC with with potent antitumor activity by using DM1 (Mertansine, a tubulin inhibitor) , linked via the ADC linker SC-VC-PAB .
loading...
    loading...
Cat. No.: HY-100931
CAS No.: 102649-79-6
Purity:  98.65%
Target:  

PKC

Research Areas:  

Cancer

SC-10 is a direct activator of PKC .
loading...
    loading...